Total Funding
64
70
Total FundingPost-IPO Equity raised
Growth Score 64 in past quarter
-3 pts
Heat Score 70 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
223388
Australis Capital is a pharmaceutical public company that develops and helps grow the cannabis industry to meet the growing market demand.
- Jason Dyck: CSO
- Duke Du: COO
About the Company
Australis Capital is a pharmaceutical public company that develops and helps grow the cannabis industry to meet the growing market demand. AUSA synthesizes decades of relevant expertise, strategic alignments, and capital investment to identify, acquire, and partner with companies setting the high-quality standards required to meet the growing
market demand.
It was founded in 2018 and is headquartered in Las Vegas, Nevada.